These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26739586)

  • 41. [Renal denervation 2013].
    Spinar J; Vítovec J; Spinarová L
    Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal denervation for the management of resistant hypertension.
    Patel HC; Hayward C; Vassiliou V; Patel K; Howard JP; Di Mario C
    Integr Blood Press Control; 2015; 8():57-69. PubMed ID: 26672761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?
    Tsioufis C; Dimitriadis K; Kordalis A; Doumas M; Konstantinidis D; Kalos T; Mahfoud F; Papademetriou V; Tousoulis D
    Curr Vasc Pharmacol; 2017; 16(1):66-69. PubMed ID: 28462714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal Artery Denervation in Resistant Hypertension: The Good, The Bad and The Future.
    Al Raisi SI; Pouliopoulos J; Swinnen J; Thiagalingam A; Kovoor P
    Heart Lung Circ; 2020 Jan; 29(1):94-101. PubMed ID: 31327701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New opportunities of renal denervation].
    Agaeva RA; Danilov NM; Shelkova GV; Matchin YG; Chazova IE
    Ter Arkh; 2020 Jul; 92(6):84-88. PubMed ID: 33346499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.
    Mountfort K; Mahfoud F; Schmieder R; Davies J; Kandzari DE; Weil J; Whitbourn R
    Interv Cardiol; 2013 Aug; 8(2):118-123. PubMed ID: 29588763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal Denervation: Where to Now?
    Wimmer NJ; Mauri L
    Curr Cardiol Rep; 2015 Dec; 17(12):116. PubMed ID: 26482759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
    Briasoulis A; Bakris G
    Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal Denervation: Past, Present, and Future.
    Hannawi B; Ibrahim H; Barker CM
    Rev Cardiovasc Med; 2015; 16(2):114-24. PubMed ID: 26198558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
    Al-Fakhouri A; Efeovbokhan N; Nakhla R; Khouzam RN
    Rev Port Cardiol; 2016 Oct; 35(10):531-8. PubMed ID: 27614724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal denervation for hypertension: observations and predictions of a founder.
    Esler M
    Eur Heart J; 2014 May; 35(18):1178-85. PubMed ID: 24598982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating Hypertension Using Renal Artery Denervation: Problems and Progress.
    Townsend RR
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):117-121. PubMed ID: 31023445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sympathetic renal denervation: hypertension beyond SYMPLICITY.
    Barbash IM; Waksman R
    Cardiovasc Revasc Med; 2013; 14(4):229-35. PubMed ID: 23928314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistant hypertension in 2017.
    Hans S; Reilly JP
    Curr Opin Cardiol; 2017 Jul; 32(4):389-396. PubMed ID: 28505045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal Denervation: a Field in Flux.
    Laffin LJ; Bakris GL
    Curr Hypertens Rep; 2016 Jul; 18(7):56. PubMed ID: 27245681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eligibility for renal denervation: experience at 11 European expert centers.
    Persu A; Jin Y; Baelen M; Vink E; Verloop WL; Schmidt B; Blicher MK; Severino F; Wuerzner G; Taylor A; Pechère-Bertschi A; Jokhaji F; Fadl Elmula FE; Rosa J; Czarnecka D; Ehret G; Kahan T; Renkin J; Widimsky J; Jacobs L; Spiering W; Burnier M; Mark PB; Menne J; Olsen MH; Blankestijn PJ; Kjeldsen S; Bots ML; Staessen JA;
    Hypertension; 2014 Jun; 63(6):1319-25. PubMed ID: 24664290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y; Persu A; Staessen JA
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.